Ostovir Capsule

Introduction

Ostovir is a prescription medication that contains the active ingredient Oseltamivir Phosphate. It is available in capsule form and is commonly known by its generic name. This medication is primarily used for the treatment and prevention of influenza, commonly known as the flu.

Uses

Ostovir is indicated for the treatment of influenza in patients aged 14 days and older. It can also be used for the prevention of influenza in patients aged 1 year and older who have been exposed to the flu virus. Note that this medication is not a substitute for the flu vaccine and should be used in conjunction with recommended vaccination strategies.

Dosage and Administration

The dosage of Ostovir varies depending on the age and weight of the patient, as well as the specific indication for use. Follow the instructions provided by your healthcare professional or the prescribing information. Typically, this medication is taken orally with or without food. For treatment of influenza, the recommended dosage and duration of treatment will be determined by your healthcare provider.

Mechanism of Action

Ostovir works by inhibiting the enzyme neuraminidase, which is necessary for the release of influenza virus particles from infected cells. By blocking this enzyme, the medication helps to reduce the spread of the virus in the body and alleviate symptoms associated with influenza.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, headache, and dizziness. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as allergic reactions, difficulty breathing, or changes in behavior, seek medical attention immediately.

Drug Interactions

Ostovir may interact with certain medications, including those used to treat viral infections, such as zanamivir and amantadine. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential drug interactions.

Precautions

Before taking Ostovir, inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for everyone, especially those with kidney problems or a history of psychiatric disorders. Note that this medication may not be effective against all strains of influenza, and its use should be guided by the current recommendations of public health authorities.

Storage

Ostovir should be stored at room temperature, away from moisture and heat. Keep the medication out of the reach of children and dispose of any unused capsules properly, in accordance with local regulations.

Patient Tips

• Take Ostovir exactly as prescribed by your healthcare provider.
• If you are using this medication for the prevention of influenza, start treatment as soon as possible after exposure to the virus.
• If you experience any side effects, contact your healthcare provider for further guidance.
• Remember that Ostovir is not a substitute for the flu vaccine, and it is still important to get vaccinated as recommended by healthcare professionals.
• If your symptoms worsen or do not improve after a few days of treatment, consult your healthcare provider for further evaluation.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Phosphate test (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Oseltamivir 30 mg Hard Capsules (Health Professionals SmPC) Available at:
• Oseltamivir (Drugs.com) [Accessed 12 Jun. 2024] (online) Available at:
• oseltamivir phosphate (RX) [Accessed 7 Jun. 2024] (online) Available at:
• What are Flu Antiviral Drugs (Centers for Disease Control and Prevention) [Accessed 23 Jun. 2024] (online) Available at:
• Shaim H, McCaffrey P, Trieu JA, DeAnda A, Yates SG. Evaluating the effects of oseltamivir phosphate on platelet counts: a retrospective review. Platelets. 2020 Nov 16;31(8):1080-1084. doi: 10.1080/09537104.2020.1714576. Epub 2020 Jan 13. [Accessed 10 Jun. 2024] Available at: